It really does sound like fatty liver/hyperlipemia. Heres an online article about it. While this is more rare in big horses it is not rare at all in minis.
Epidemiology and Pathogenesis:
Poor feed quality or decrease in feed intake, particularly during a period of high-energy requirement (eg, pregnancy, systemic disease), may result in hyperlipemia syndrome. Hyperlipemia is seen most commonly in ponies, miniature horses, and donkeys, and less frequently in standard-size adult horses. Pathogenesis of hyperlipemia is complex, with a negative energy balance triggering excessive mobilization of fatty acids from adipose tissue leading to increased hepatic triglyceride synthesis and secretion of very low density lipoproteins, concomitant hypertriglyceridemia, and fatty infiltration of the liver. The biochemical etiology of hyperlipemia is overproduction of triglyceride, rather than failure of triglyceride catabolism.
Onset of disease is associated with stress, decreased feed intake, fat mobilization and deposition in the liver, and overproduction of triglycerides, which may be precipitated by insulin resistance. In ponies, hyperlipemia is usually a primary disease process associated with obesity, pregnancy, lactation, stress, or transportation. Hyperlipemia may develop secondary to any systemic disease that results in anorexia and a negative energy balance. Secondary hyperlipemia is more common than primary hyperlipemia in miniature breeds. Hyperlipemia secondary to a systemic disease can be seen in horses of any age and in any condition. Female, stressed, and obese donkeys are at highest risk of developing hyperlipemia regardless of pregnancy status. Hyperlipemia is most commonly seen in the winter and spring.
Back to top
Clinical Findings:
Signs are nonspecific, variable, and may not relate to loss of liver function. They include lethargy, weakness, inappetence, decreased water intake, and diarrhea. Often, there is a history of prolonged anorexia, rapid weight loss, and previous obesity. Emaciation, ventral edema, colic, and trembling may be seen. Serum biochemical values and coagulation testing in miniature horses and ponies with hyperlipemia indicate that impairment of hepatic function is common. Affected animals have grossly opalescent blood and lipemic plasma. The blood concentrations of all lipids are increased, especially triglycerides, nonesterified fatty acids, and very-low-density lipoproteins. Donkeys have higher plasma triglyceride concentrations than do other equids. Hypoglycemia is a common finding in ponies but not in miniature horses with hyperlipemia. Total bile acid concentration and BSP® clearance are often normal, but BSP clearance may be prolonged in some animals. Activated partial thromboplastin time and one-stage prothrombin time may be prolonged. AST and SDH may be normal or increased. Increased creatinine, isosthenuria, and metabolic acidosis may develop secondary to renal disease. BUN and creatinine values are variable. Anorexia can lead to hypokalemia. Animals may become neutropenic with increased band neutrophils. Concurrent pancreatitis has been reported.
Prolonged increase in serum triglyceride concentrations is associated with lipid accumulation in the liver, kidneys, myocardium, and skeletal muscles, impairing function of these organs. The liver and kidneys become friable, and death may result from acute hepatic rupture.
Alpacas and llamas may develop hyperlipemia and ketonuria in late stages of gestation or secondary to disease states. Nonspecific clinical signs include lethargy, anorexia, and recumbency. Hypertriglyceridemia, hypercholesterolemia, increased SDH activity, metabolic acidosis, azotemia, and ketonuria may be seen. Secondary renal failure may develop. Camelids appear to be similar to both horses (hyperlipidemia) and cattle (ketosis) in their response to severe energy imbalance in late gestation. Hepatic lipidosis is the most common liver disease found in llamas and alpacas. Camelids of various ages and energy requirements are susceptible, and the pathogenesis is multifactorial. Common clinical findings include anorexia, weight loss, high concentrations of bile acids, high activities of GGT and AST, and hypoproteinemia. Some animals have high nonesterified fatty acids and β-hydroxybutyrate concentrations.
Lesions:
The liver and kidneys are often pale, swollen, and friable with a greasy texture. Microscopically, there is variable fat deposition within the hepatocytes and epithelium of the bile ducts. The hepatic sinusoids may appear compressed and anemic with severe fatty infiltration. Gross and microscopic lesions of the primary disease process in ponies and horses may predominate.
Back to top
Diagnosis:
Photographs
Hyperlipemia, horse
Hyperlipemia, horse
Clinical diagnosis is often based on the signalment, history, clinical signs, and gross observation of a white to yellow discoloration of the plasma. Plasma or serum triglyceride levels >500 mg/dL confirm the diagnosis. Cholesterol may also be increased, indicating an increase in lipoprotein. Laboratory evidence of hepatic dysfunction is supportive.
Back to top
Treatment:
Correction of the underlying disease, IV fluids, and nutritional support are the most essential factors in treatment of hyperlipemia. Nutritional support reverses the negative energy balance, increases serum glucose concentrations, promotes endogenous insulin release, and inhibits mobilization of peripheral adipose tissue. Polyionic electrolyte solution containing supplemental dextrose (50 g/hr/450 kg) and potassium (20-40 mEq of potassium chloride/L) should be given IV to hypoglycemic, hypokalemic animals. Glucose administration may cause refractory hyperglycemia in animals with insulin resistance. Glucose levels, renal function, urine output, and serum electrolyte concentrations should be monitored closely. IV fluids must be administered cautiously in camelids with hepatic lipidosis as many are already hypoproteinemic. Intermittent bolus administration of IV fluids rather than continuous infusion may be more effective for maintaining hydration without exacerbating existing hypoproteinemia.
Voluntary enteral nutrition is preferred if the affected animal will consume adequate quantities of nutritionally valuable feeds; however, most will not. Frequent feedings of a high-carbohydrate, low-fat diet are preferred. In animals with inadequate oral intake, supplemental tube feeding is necessary. Commercially available high-calorie enteral formulations provide adequate short-term nutritional support. Recipes for home-prepared, liquid tube-feeding diets for horses are also available. Small frequent feedings are required to meet caloric needs without overloading the GI tract. Animals should be observed after each feeding for signs of abdominal discomfort. Body weight, total fluid intake, and fecal consistency should be monitored daily. In animals that survive, hyperlipemia usually resolves in 5-10 days, but enteral feeding should be continued until voluntary feed intake is adequate. Enteral nutritional supplementation and treatment of the primary disease is often successful in reversing hyperlipemia in miniature horses and donkeys but not in ponies.
For horses that are totally anorectic, parenteral nutrition may be used. The lipid portion of the solution is omitted. Blood glucose concentration should be monitored twice daily to ensure that euglycemia is maintained and that substantial hyperglycemia (≥180 mg/dL) is avoided.
In camelids, partial parenteral nutrition with enteral supplementation can be used to maintain adequate energy intake and minimize further fat mobilization. Because of the distinct metabolism of camelids, parenteral nutrition products must contain higher amounts of amino acids (relative to nonprotein calories) than traditional formulations used in other species. Glucose concentrations must be carefully monitored, as these animals do not assimilate exogenous glucose well.
Exogenous insulin administration is recommended for treatment of iatrogenic hyperglycemia and hyperlipemia. Insulin decreases mobilization of peripheral adipose tissue by stimulating lipoprotein lipase activity and by inhibiting adipocyte hormone-sensitive lipase activity. The appropriate dose of insulin to be used in horses has not been well established. When insulin is used, response to therapy must be closely monitored and the dose adjusted accordingly. Insulin administration may fail to lower serum triglyceride or glucose concentrations in hyperlipemic animals when an insulin-resistant state is present. Insulin treatment is not well documented in camelids but was reportedly effective in the treatment of llamas with hepatic lipidosis.
Heparin is used in treatment of hyperlipemia because it promotes peripheral utilization of triglycerides and enhances lipogenesis via stimulation of lipoprotein lipase activity. Heparin may be given IV or SC with recommended dosages of 40-100 IU/kg, bid . Use of heparin is questionable in affected animals with increased hepatic production of triglycerides and without impaired peripheral removal of triglycerides. Heparin administration may potentiate bleeding complications and is contraindicated in animals with coagulopathies from liver dysfunction.
Nutritional supplementation to prevent hyperlipemia is indicated in miniature horses and donkeys, ponies, and horses with systemic disease associated with hypophagia and high metabolic demands.
Back to top
Prognosis:
Clinical biochemical parameters are not useful prognostic indicators of survival in ponies with hyperlipemia. Death from hyperlipemia is rare in miniature breeds. In most instances, survival depends on the ability to successfully treat the primary disease. Prognosis is often poor in ponies, standard-size horses, and camelids.
Back to top
See Also
:arg!
